Sara Mangsbo

Sara Mangsbo is Associate senior lecturer and Associate professor at Uppsala University and Chief Development Officer at Ultimovacs ASA/AB. Associate professor Mangsbo have a track record in drug development within immuno-oncology with a focus on antibody and peptide-based immunotherapies. In addition she has co-founded Immuneed AB, a company that provides a unique human whole blood assay for drug efficacy and toxicity assessment in preclinical testing and Vivologica AB that provides an efficient data management platform for preclinical research.

Please feel free to share this...